Testing effectiveness (Phase 2)Study completedNCT00866502
What this trial is testing
A Safety and Tolerability Study of Intracerebroventricular Administration of sNN0031 to Patients With Parkinson's Disease
Who this might be right for
Parkinson's Disease
Newron Sweden AB 12